发明名称 |
Agent for suppressing elevation of blood GIP concentration |
摘要 |
An agent for suppressing elevation of blood GIP concentration and an agent for preventing or improving obesity, each of which contains a polyglutamic acid as an active ingredient. |
申请公布号 |
US8853153(B2) |
申请公布日期 |
2014.10.07 |
申请号 |
US201013383658 |
申请日期 |
2010.07.16 |
申请人 |
Kao Corporation |
发明人 |
Ishimaru Kotomi;Sawada Kazuhisa;Shimotoyodome Akira |
分类号 |
A61K38/00;A61P3/04;C08G69/10;A61K31/785 |
主分类号 |
A61K38/00 |
代理机构 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
代理人 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
主权项 |
1. A method of suppressing the rate of increase in body weight of a human subject, comprising administering to said subject 0.001 to 1.0 g of polyglutamic acid/kg body weight per day, wherein said polyglutamic acid is administered in a solid or liquid composition that either consists of polyglutamic acid or comprises a polyglutamic acid formulation, wherein the polyglutamic acid has a weight average molecular weight of 9,000 to 5,000,000;
wherein the subject meets at least two of the following criteria: (1) an abdominal girth of 102 cm or more for a man and 88 cm or more for a woman; (2) a blood triglyceride level of 150 mg/dl or more or HDL cholesterol of less than 40 mg/dl, (3) a fasting blood sugar level of 110 mg/dl or more; and (4) a blood pressure of 130/85 mHg or more and suppressing the rate of increase in said subject's body weight as a result of said administering. |
地址 |
Tokyo JP |